M&A / Deals GBL joins CVC in 10.7bn takeover bid for Recordati PharmaphorumA consortium of investors has made a 10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.Read full story pharminent May 22, 2026 (Last updated: May 22, 2026) Pharmaphorum A consortium of investors has made a 10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Gilead Sciences completes Tubulis acquisition for $5bnNext: Gilead inks $140M API supply deal, tightening ties to Korean manufacturer Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
